Laidlaw Wealth Management »

Regeneron Pharmaceuticals shares owned by Laidlaw Wealth Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Laidlaw Wealth Management from 13F filings

Historical chart of Laidlaw Wealth Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Laidlaw Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Laidlaw Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $447k 509 878.29
2023-09-30 $310k 377 822.96
2023-06-30 $311k 433 718.54
2023-03-31 $388k 472 821.67
2022-12-31 $341k 472 721.49
2022-09-30 $327k 474 689.87
2022-06-30 $260k 440 590.91
2022-03-31 $307k 440 697.73
2021-12-31 $279k 442 631.22
2021-09-30 $264k 437 604.12
2021-06-30 $246k 440 559.09
2020-12-31 $208k 431 482.60
2020-09-30 $236k 422 559.24